SIR calls for updated policy on radioembolization procedure | ACR offers White House AI regulation recs | LLMs fail boards

SIR contends that payments toward transarterial radioembolization (TARE)/selective internal radiation therapy (SIRT) should extend beyond the current coverage limitations in patients with liver cancer and metastases. 

ACR’s input is included as part of America’s AI Action Plan, which was created to help implement emerging AI technologies into everyday workflows. 

The company offers a suite of services including AI-powered safety monitoring in case something goes wrong in the MRI suite, staffing, training and certification. 

Updated large language models have been trained to process both text- and image-based questions, potentially making them more effective in radiology settings. 

The new Class I recall covers nearly 18,000 insulin pumps distributed throughout the United States. While this is not a product removal, users are being urged to update their devices immediately. 

A system-wide initiative in Sweden helped hospitals reduce readmission rates and shorten lengths of stay. When it came to heart failure patients specifically, however, the changes barely made an impact.

Novo Nordisk and Eli Lilly have agreed to sell their popular Wegovy and Zepbound injectables through TrumpRx.gov for a discounted rate, as the White House promises that Medicaid and Medicare plans will begin covering the costs. 

The findings are from research conducted by the Commonwealth Fund that looked at nationwide provider reimbursement data. While the sample size is small, it shows the insurer tends to favor its own doctors.